Glomerular filtration rate of 51ml/min is allowed to take Piperazine Ferulate Tablets.
Piperazine Ferulic Acid Tablets is an oral anticoagulant, its pharmacological effect is to have anticoagulation, improve microcirculation, inhibit platelet aggregation, dilate the renal microvessels, enhance the blood flow of the kidneys, it can be used as an adjunctive drug for patients with chronic glomerular disease and chronic renal failure to slow down the progression of the disease.
The patient’s glomerular filtration rate of 51ml/min, if belongs to the chronic change, indicates that it has reached the stage 3 of chronic kidney disease, in this stage, the kidney has already appeared most of the glomerulosclerosis, and it can be utilized to slow down the progression of kidney disease by the efficacy of Ferulic Acid Piperazine Tablets.
Although patients with chronic kidney disease can take Piperazine Ferulic Acid Tablets orally, they need to be applied under the guidance of a professional doctor, because Piperazine Ferulic Acid Tablets have the efficacy of anticoagulation and antiplatelet aggregation, and there may be the risk of bleeding if not used in a standardized way.
Patients with reduced glomerular filtration rate are advised to consult a regular hospital in a timely manner and follow the doctor’s instructions for standardized treatment, do not self-medicate.